Experimental cancer drug shows therapeutic promise in mouse models of multiple sclerosis

Posted · Add Comment
scidaily-logo-rss

An experimental drug originally identified in a National Cancer Institute library of chemical compounds as a potential therapy for brain and basal cell cancers improves the symptoms of mice with a form of the debilitating neurological disorder multiple sclerosis (MS), according to new research.

This full article appears on <a href="http://www.sciencedaily.com/releases/2015/09/150930140621.htm">Science Daily</a>

Leave a Reply

Your email address will not be published. Required fields are marked *